Form 483

Glaxo Operations UK Ltd Form 483, 2019-09-06

FDA issued a Form 483 to Glaxo Operations UK Ltd on 2019-09-06 with 1 public-safe observation.

483· Form 483 issuedHuman Drugs1 observation

Glaxo Operations UK Ltd · Ware, United Kingdom · Issued September 6, 2019

Overview

  • 1 public-safe observation is available for this inspection.
  • 1 structured CFR citation is represented.
  • 1 investigator is tied to this Form 483.

Inspectional observations

Each observation cites the regulation FDA found the firm out of compliance with.

6 Sep 2019
21 CFR 211.113(a)

Procedures for non-sterile drug products

Cited by Erika V Butler

Inspected site

GOGlaxo Operations UK LtdWare, United Kingdom

Inspection team

Cited regulations

CFR citations associated with this Form 483.

CitationWhat it coversCited
21 CFR 211.113(a)Cited across public-safe Form 483 observations1x

Source document

PDF
PDF available

Form 483 source document

The source document is available to authorized Atlas users.

Full 483 report

Get the verbatim text of all 1 observation

The source PDF and every observation in full, so your team sees exactly what was cited and how it was answered.

  • The site's full inspection history around this Form 483
  • Whether these citations escalated to a warning letter
  • The investigators involved and the citations they repeat elsewhere